

HY-141431 · 1 mg
MedChemExpress · Cat: HY-141431
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/cbl-b-in-2.htmlDescription
Cbl-b-IN-2 Example 8 is an orally bioavailable compound, can inhibit the E3 enzyme Casitas B-lineage lymphoma proto-oncogene-b Cbl-b in the ubiquitin proteasome pathway. Cbl-b-IN-2 can be used to modulate the immune system and diseases amenable to immune system modulation. Cbl-b-IN-2 Example 8 also may be administered to an individual with cancer, either alone or as part of a combination, with one or more of an immune checkpoint inhibitor, an anti-neoplastic agent, and radiation agent.







